StockDrifts LogoStockDrifts

Kyungnam Pharmaceutical 053950

Company
경남제약Kyungnam Pharmaceutical
Insiders
1
Buys
3
Total Value
₩10.2B ($7.1M)
Avg Return
-28.86%
Last Filing
2026-07-02

Kyungnam Pharmaceutical (053950) has 3 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩10.2B ($7.1M) in reported transaction value. The earliest filing StockDrifts holds for Kyungnam Pharmaceutical is dated 2024-02-13; the most recent is 2026-07-02. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -28.86%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-02BUY제3자배정유상증자
엑스
X
-4.0M₩1,640-6.0%₩6.5B ($4.5M)
2026-04-16SELL주식병합
빌리언스
Billions
--11.2M₩769+0.0%₩8.6B ($6.0M)
2024-11-05BUYMarket Buy
미니쉬테크놀로지
Minish Technology
-6.6M₩951-35.1%₩6.2B ($4.3M)
2024-11-04BUYMarket Buy
미니쉬테크놀로지
Minish Technology
-1.0M₩785-21.4%₩821M ($570K)
2024-11-01BUYMarket Buy
미니쉬테크놀로지
Minish Technology
-3.6M₩882-30.1%₩3.2B ($2.2M)
2024-10-23BUY유상신주취득
빌리언스
Billions
-6.9M₩662-6.8%₩4.6B ($3.2M)
2024-10-23SELL기타
빌리언스
Billions
--6.9M₩662+6.8%₩4.6B ($3.2M)
2024-10-23BUY유상신주취득
미니쉬테크놀로지
Minish Technology
-3.0M₩662-6.8%₩2.0B ($1.4M)
2024-09-12BUY기타
빌리언스
Billions
-6.9M₩810-23.8%₩5.6B ($3.9M)
2024-05-17SELL장외매도
스페이셜인베스트먼트
Spatial Investment
--3.4M₩964+36.0%₩3.3B ($2.3M)
2024-05-10BUY행사가액조정
스페이셜인베스트먼트
Spatial Investment
-283.5K₩832-25.8%₩236M ($164K)
2024-04-11SELL행사가액조정
스페이셜인베스트먼트
Spatial Investment
--242.3K₩828+25.5%₩201M ($139K)
2024-03-11BUY행사가액조정
스페이셜인베스트먼트
Spatial Investment
-232.9K₩828-25.5%₩193M ($134K)
2024-02-13BUY행사가액조정
스페이셜인베스트먼트
Spatial Investment
-535.8K₩896-31.1%₩480M ($333K)

Frequently asked questions

Who has been buying Kyungnam Pharmaceutical stock?
1 distinct insiders have filed 3 disclosed insider purchases in Kyungnam Pharmaceutical (053950), most recently on 2026-07-02. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Kyungnam Pharmaceutical have?
Kyungnam Pharmaceutical has 3 buy-side and 0 sell-side disclosures on record, covering ₩10.2B ($7.1M) in total reported value, spanning 2024-02-13 to 2026-07-02.
Where does StockDrifts get Kyungnam Pharmaceutical insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Kyungnam Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.